Blasts Under 25 Percent of Bone Marrow Nucleated Cells Clinical Trials in Washington D.C., District of Columbia

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant